Dermal CD207-Negative Migratory Dendritic Cells Are Fully Competent to Prime Protective, Skin Homing Cytotoxic T-Lymphocyte Responses.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
02 2019
Historique:
received: 30 04 2018
revised: 14 08 2018
accepted: 28 08 2018
pubmed: 9 10 2018
medline: 1 1 2020
entrez: 9 10 2018
Statut: ppublish

Résumé

Dendritic cells (DCs) are important inducers and regulators of T-cell responses. They are able to activate and modulate the differentiation of CD4

Identifiants

pubmed: 30296420
pii: S0022-202X(18)32650-2
doi: 10.1016/j.jid.2018.08.022
pii:
doi:

Substances chimiques

Epitopes, T-Lymphocyte 0
Histocompatibility Antigens Class I 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

422-429

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Tobias Hain (T)

Institute for Immunology, University Medical Center Mainz, Germany; Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany.

Felix Melchior (F)

Institute for Immunology, University Medical Center Mainz, Germany; Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany.

Nadine Kamenjarin (N)

Institute for Immunology, University Medical Center Mainz, Germany; Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany.

Sabine Muth (S)

Institute for Immunology, University Medical Center Mainz, Germany; Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany.

Hela Weslati (H)

Institute for Immunology, University Medical Center Mainz, Germany; Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany.

Björn E Clausen (BE)

Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany; Institute for Molecular Medicine, University Medical Center Mainz, Mainz, Germany.

Karsten Mahnke (K)

Department of Dermatology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.

Cinthia Silva-Vilches (C)

Department of Dermatology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.

Kristian Schütze (K)

Institute for Immunology, University Medical Center Mainz, Germany; Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany.

Julian Sohl (J)

Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany; Third Department of Medicine-Hematology, Oncology, Pneumology, University Medical Center Mainz, Mainz, Germany.

Markus P Radsak (MP)

Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany; Third Department of Medicine-Hematology, Oncology, Pneumology, University Medical Center Mainz, Mainz, Germany.

Georg Bündgen (G)

Institute for Immunology, University Medical Center Mainz, Germany; Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany.

Tobias Bopp (T)

Institute for Immunology, University Medical Center Mainz, Germany; Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany.

Sven Danckwardt (S)

Posttranscriptional Gene Regulation and Experimental Hemostasis, University Medical Center Mainz, Mainz, Germany; Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Mainz, Germany; Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany.

Hansjörg Schild (H)

Institute for Immunology, University Medical Center Mainz, Germany; Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany.

Hans Christian Probst (HC)

Institute for Immunology, University Medical Center Mainz, Germany; Research Centre for Immunotherapy, University Medical Center Mainz, Mainz, Germany. Electronic address: hcprobst@uni-mainz.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH